Virological characteristics correlating with SARS-CoV-2 spike protein fusogenicity

被引:6
|
作者
Begum, M. S. T. Monira [1 ]
Ichihara, Kimiko [1 ]
Takahashi, Otowa [1 ]
Nasser, Hesham [1 ,2 ]
Jonathan, Michael [1 ,3 ]
Tokunaga, Kenzo [4 ]
Yoshida, Isao [5 ]
Nagashima, Mami [5 ]
Sadamasu, Kenji [5 ]
Yoshimura, Kazuhisa [5 ]
Sato, Kei [6 ,7 ,8 ,9 ,10 ,11 ,12 ]
Ikeda, Terumasa [1 ]
机构
[1] Kumamoto Univ, Joint Res Ctr Human Retrovirus Infect, Div Mol Virol & Genet, Kumamoto, Japan
[2] Suez Canal Univ, Fac Med, Dept Clin Pathol, Ismailia, Egypt
[3] Kumamoto Univ, Grad Sch Med Sci, Kumamoto, Japan
[4] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan
[5] Tokyo Metropolitan Inst Publ Hlth, Tokyo, Japan
[6] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Syst Virol, Tokyo, Japan
[7] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo, Japan
[8] Univ Tokyo, Inst Med Sci, Int Vaccine Design Ctr, Tokyo, Japan
[9] Univ Tokyo, Grad Sch Med, Tokyo, Japan
[10] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan
[11] Kumamoto Univ, Joint Res Ctr Human Retrovirus Infect, Collaborat Unit Infect, Kumamoto, Japan
[12] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan
来源
FRONTIERS IN VIROLOGY | 2024年 / 4卷
关键词
SARS-CoV-2; fusogenicity; pathogenicity; S1/S2 cleavage efficiency; plaque size; pseudoviral infectivity; pseudovirus entry efficiency; viral replication kinetics; NEURONAL CELLS; FUSION; SPREAD;
D O I
10.3389/fviro.2024.1353661
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction The severe acute respiratory syndrome coronavirus (SARS-CoV-2) spike (S) protein is essential in mediating membrane fusion of the virus with the target cells. Several reports demonstrated that SARS-CoV-2 S protein fusogenicity is reportedly closely associated with the intrinsic pathogenicity of the virus determined using hamster models. However, the association between S protein fusogenicity and other virological parameters remains elusive.Methods In this study, we investigated the virological parameters (e.g., S1/S2 cleavage efficiency, plaque size, pseudoviral infectivity, pseudovirus entry efficiency, and viral replication kinetics) of eleven previous variants of concern (VOCs) and variants of interest (VOIs) correlating with S protein fusogenicity.Results and discussion S protein fusogenicity was found to be strongly correlated with S1/S2 cleavage efficiency and plaque size formed by clinical isolates. However, S protein fusogenicity was less associated with pseudoviral infectivity, pseudovirus entry efficiency, and viral replication kinetics. Taken together, our results suggest that S1/S2 cleavage efficiency and plaque size could be potential indicators to predict the intrinsic pathogenicity and S protein fusogenicity of newly emerged SARS-CoV-2 variants.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity
    Pal, Debnath
    JOURNAL OF STRUCTURAL BIOLOGY, 2021, 213 (02)
  • [2] Temperature impacts SARS-CoV-2 spike fusogenicity and evolution
    Dufloo, Jeremy
    Sanjuan, Rafael
    MBIO, 2024, 15 (04):
  • [3] Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
    Yamasoba, Daichi
    Kimura, Izumi
    Nasser, Hesham
    Morioka, Yuhei
    Nao, Naganor
    Ito, Jumpei
    Uriu, Keiya
    Tsuda, Masumi
    Zahradnik, Jiri
    Shirakawa, Kotaro
    Suzuki, Rigel
    Kishimoto, Mai
    Kosugi, Yusuke
    Kobiyama, Kouji
    Hara, Teppei
    Toyoda, Mako
    Tanaka, Yuri L.
    Butlertanaka, Erika P.
    Shimizu, Ryo
    Ito, Hayato
    Wang, Lei
    Oda, Yoshitaka
    Orba, Yasuko
    Sasaki, Michihito
    Nagata, Kayoko
    Yoshimatsu, Kumiko
    Asakura, Hiroyuki
    Nagashima, Mami
    Sadamasu, Kenji
    Yoshimura, Kazuhisa
    Kuramochi, Jin
    Seki, Motoaki
    Fujiki, Ryoji
    Kaneda, Atsushi
    Shimada, Tadanaga
    Nakada, Taka-aki
    Sakao, Seiichiro
    Suzuki, Takuji
    Ueno, Takamasa
    Takaori-Kondo, Akifumi
    Ishii, Ken J.
    Schreiber, Gideon
    Sawa, Hirofumi
    Saito, Akatsuki
    Irie, Takashi
    Tanaka, Shinya
    Matsuno, Keita
    Fukuhara, Takasuke
    Ikeda, Terumasa
    Sato, Kei
    CELL, 2022, 185 (12) : 2103 - +
  • [4] SARS-CoV-2 Delta spike protein enhances the viral fusogenicity and inflammatory cytokine production
    Ao, Zhujun
    Ouyang, Maggie Jing
    Olukitibi, Titus Abiola
    Yao, Xiaojian
    ISCIENCE, 2022, 25 (08)
  • [5] Virological characteristics and diagnosis of SARS-CoV-2
    Reina, Jordi
    Fraile, Pablo
    MEDICINA BALEAR, 2020, 35 (04): : 62 - 68
  • [6] Virological and Mitochondriopathogical Characteristics of the SARS-CoV-2 Omicron XBB.1.16 Spike
    Fang, Liaoxin
    Kang, Xiaofeng
    Hong, Qian
    Xue, Chunyuan
    Pan, Lu
    Chen, Jiaxin
    Tang, Chuanhao
    Sun, Liying
    Xu, Xiaojie
    Yuan, Jing
    Du, Yimeng
    Xu, An
    ACS APPLIED MATERIALS & INTERFACES, 2024, 16 (23) : 29716 - 29727
  • [7] Amyloidogenesis of SARS-CoV-2 Spike Protein
    Nystrom, Sofie
    Hammarstrom, Per
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2022, 144 (20) : 8945 - 8950
  • [8] SARS-CoV-2 and the spike protein in endotheliopathy
    Perico, Luca
    Benigni, Ariela
    Remuzzi, Giuseppe
    TRENDS IN MICROBIOLOGY, 2024, 32 (01) : 53 - 67
  • [9] Structure of SARS-CoV-2 spike protein
    Zhang, Jun
    Xiao, Tianshu
    Cai, Yongfei
    Chen, Bing
    CURRENT OPINION IN VIROLOGY, 2021, 50 : 173 - 182
  • [10] Virological characteristics of the SARS-CoV-2 XEC variant
    Kaku, Yu
    Okumura, Kaho
    Kawakubo, Shusuke
    Uriu, Keiya
    Chen, Luo
    Kosugi, Yusuke
    Uwamino, Yoshifumi
    Begum, M. S. T. Monira
    Leong, Sharee
    Ikeda, Terumasa
    Sadamasu, Kenji
    Asakura, Hiroyuki
    Nagashima, Mami
    Yoshimura, Kazuhisa
    Ito, Jumpei
    See, Kei Sato
    LANCET INFECTIOUS DISEASES, 2024, 24 (12): : e736 - e736